Romosozumab reduces incidence of new vertebral fractures across severity grades among postmenopausal women with osteoporosis

P. Geusens*, R. Feldman, M. Oates, T. Thomas, P. Makras, F. Jakob, B. Langdahl, Z.X. Wang, M. Rojeski, C. Libanati

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number116209
Number of pages8
JournalBone
Volume154
DOIs
Publication statusPublished - 1 Jan 2022

Keywords

  • Osteoporosis
  • Anabolics
  • Clinical trials
  • RISK
  • PREVALENT
  • ASSOCIATION
  • ALENDRONATE
  • MANAGEMENT

Cite this